We coupled a high-performance liquid chromatograph with a continuous-flow microanalyzer to produce a system for specifically determining "true" creatinine in urine and serum specimens. A selective microbore pellicular cation-exchange column and a single eluting sodium citrate buffer are used to separate the noncreatinine but Jaff#{233}-positive constituents from the creatinine in normal and experimental specimens. The effluent is analyzed continuously, on-line, the alkaline picrate complex being developed and measured in the microanalyzer. Physiological samples, reference standards, and internal control specimens are assayed in 6-mm intervals subsequent to the initial injection. The relationship between concentration and peak area is linear for creatinine standards between 5 and 10 mg/liter. Specimen volumes ranging from 1 to 25 tl, and containing creatinine in amounts exceeding 5 ng per injected sample, can be assayed with this system.
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Measurement
of serum creatinine has been assuming a steadily increasing role in assessing the progress of the patient with reduced renal function (1- continuous-flow analyzer, we can separate and measure creatinine in untreated serum and urine specimens accurately and reproducibly.
Any interfering Jaff#{233}-positivecompounds in the sample are removed by the cation-exchange column before the creatinine is eluted. With this new technique, one now can detect subtle metabolic differences in the clinical profile of the patient with reduced renal function.
MaterIals and Methods
A Varian LC series 4100 positive-displacement syringe pump (Varian Aerograph, Walnut Creek, Calif.
94598), coupled directly to a miniaturized
continuous-flow analyzer, was used in this study. The miniaturized analyzer described by Neeley and coworkers (6-8) was originally designed to perform various types of routine analyses at an accelerated rate and reduced cost per analysis. In the design of this new system, we focused on improving specificity for creatinine.
The layout of the system, shown diagrammatically in Figure 1 , consists of the following components: A 1.0 meter by 2.1 mm (i.d.) stainless-steel column, dry-packed with HS-Pellionex-SCX, a pellicular strong cation exchanger (Whatman, Clifton, N. J. 07014) that can be used at temperatures up to 80 #{176}C. Cross-linked polystyrene and sulfonic acid groups form the active stationary and ionogenic phases of the exchanger, respectively. The resin's capacity is about 9 microequivalents per gram of packing material. This particular type of exchanger is used in special cases where speed of analysis is of primary concern.
A 37 #{176}C heating bath, containing a 1.14 mm (i. 
Procedure
The dry-packed column contents were converted to the sodium form with the citrate buffer. Degassed sodium citrate buffer was used as the mobile phase, at a flow rate of 0.33 mi/mm. All separations were done at ambient temperatures, at column pressures ranging between 30 and 33 kg/cm2. The column effluent flowed directly into a mini-creatinine manifold, where it was mixed with saturated picric acid and sodium hydroxide in a volume ratio of 1.8/1/1 (0.33 ml/0.18 ml/0.18 ml).
Total analysis time is 6 mm per sample. No regeneration of the column is required between samples. The lower detection limit of the system is 3 mg of creatinme per liter. An on-line data acquisition system is preprogrammed to record and store the numerical values for the peaks onto a tape cassette. Peak areas of creatmine and the other Jaff#{233}-positive compounds separated are quantitated off-line, along with replotting of original data.
Results and Discussion
We analyzed and quantified a series of pure reference standards, containing creatinine in concentrations ranging from 5 to 100 mg/liter. Sample concentration and absorbance were related linearly. Coefficients of variation for these multiple analyses ranged from 0.9 to 1.8%.
Data on within-run precision were obtained by analyzing 20 specimens of a pooled serum and 20 Monitrol II control specimens. The concentration of creatinine in pooled serum was established at 9.8 ± 0.250 (SD) To study the effects of interfering substances on serum creatinine, we separate and quantified a series of Jaff#{233}-positive compounds mixed with samples of Monitrol II. Figure 2 shows the results for the seven different separations.
In each case, the concentrations of the various Jaff#{233}-positivecompounds added to Monitrol II was much higher than that encountered in normal serum samples. Except for the acetoacetic acid/Monitrol II, the observed concentration of creatinine remained constant. Even in this case, the carryover of the impurity into creatinine did not cause an error of more than 8%. Comparing our system to that of the SMA 6/60 (Technicon) continuous-flow analyzer, we analyzed 10 serum samples in duplicate. The average difference was 10%; our system usually gave lower values. One specimen gave a 150% difference. As was true here, such a large discrepancy is usually accompanied by a noncreatinine Jaff#{233}-positive prepeak that is usually high. This indicates that some of the interfering substances are not completely removed by the dialyzer in the SMA 6/60 system.
The system we describe in this report is not restricted solely to creatinine determination.
